Compounds > 3-n-methylspiperone
Page last updated: 2024-09-03

3-n-methylspiperone and mdl 100907

3-n-methylspiperone has been researched along with mdl 100907 in 2 studies

Compound Research Comparison

Studies
(3-n-methylspiperone)		Trials
(3-n-methylspiperone)		Recent Studies (post-2010)
(3-n-methylspiperone)		Studies
(mdl 100907)		Trials
(mdl 100907)		Recent Studies (post-2010) (mdl 100907)
155671,24165539

Protein Interaction Comparison

ProteinTaxonomy3-n-methylspiperone (IC50)mdl 100907 (IC50)
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.0048

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, Z; Collier, T; Fu, H; Liang, SH; Rong, J; Zhou, J1
Dannals, RF; Gründer, G; Howard, DR; Offord, SJ; Ravert, HT; Salzmann, JK; Szymanski, S; Wilson, PD; Wong, DF; Yokoi, F1

Reviews

1 review(s) available for 3-n-methylspiperone and mdl 100907

ArticleYear
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.
    Journal of medicinal chemistry, 2022, 08-25, Volume: 65, Issue:16

    Topics: Brain; Humans; Ligands; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Serotonin

2022

Other Studies

1 other study(ies) available for 3-n-methylspiperone and mdl 100907

ArticleYear
Time course of 5-HT2A receptor occupancy in the human brain after a single oral dose of the putative antipsychotic drug MDL 100,907 measured by positron emission tomography.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1997, Volume: 17, Issue:3

    Topics: Adult; Antipsychotic Agents; Brain; Carbon Radioisotopes; Female; Fluorobenzenes; Humans; Male; Piperidines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Spiperone; Time Factors; Tomography, Emission-Computed

1997